|1.||Ferdani, Riccardo: 3 articles (12/2010 - 11/2008)|
|2.||Anderson, Carolyn J: 2 articles (12/2010 - 11/2008)|
|3.||Chase, Zizwe A: 1 article (01/2015)|
|4.||Vjunov, Aleksei: 1 article (01/2015)|
|5.||Shi, Hui: 1 article (01/2015)|
|6.||Lercher, Johannes A: 1 article (01/2015)|
|7.||Zhao, Chen: 1 article (01/2015)|
|8.||Baráth, Eszter: 1 article (01/2015)|
|9.||Camaioni, Donald M: 1 article (01/2015)|
|10.||Kasakov, Stanislav: 1 article (01/2015)|
02/01/1991 - "Epidermal hyperplasia was induced in hairless mice (hr/hr) by topical n-hexadecane treatment of tail and back skin. "
01/01/1989 - "A transient epidermal hyperplasia was induced in guinea pig epidermis by a single application of n-hexadecane. "
01/01/1987 - "The application of hexadecane on animals skin induces hyperkeratinization and hyperplasia of the epidermis, however, the initial mechanisms of the epidermal cell proliferation and keratinization by hexadecane stimulation remains unknown. "
11/01/1982 - "When epidermal samples were prepared form tissue treated with hexadecane to induce hyperplasia, an increase in metabolic activity and decrease in the amplitude of diurnal variation was observed. "
11/01/1982 - "In previous studies, the rates of epidermal glycolysis and amino acid incorporation were found to parallel rates of mitosis in both the hypoplasia associated with starvation and the hyperplasia produced by treatment with hexadecane. "
|2.||B-Cell Lymphoma (Lymphoma, B Cell)
05/01/1995 - "Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane."
02/01/2006 - "n-Hexadecane (C(16)H(34)), which is present in petroleum, has adjuvant activity and induces arthritis in rodents like other lupus-inducing oils. "
10/01/1999 - "Hexadecane also completely prevented AA and squalane, methyl oleate and pristane moderately prevented AA, though pristane by itself induced mild arthritis in two out of five rats. "
12/01/2012 - "Hydrocarbon oils such as pristane or hexadecane induce arthritis and lupus in rodents sharing clinical and pathological features with the human diseases rheumatoid arthritis and systemic lupus erythematosus, respectively. "
11/01/2008 - "This report describes the synthesis and evaluation of 64Cu-CB-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-sst2-ANT (64Cu-CB-TE2A-sst2-ANT) as a PET radiopharmaceutical for the in vivo imaging of SSTR2-positive tumors. "
01/01/2014 - "Biodistribution, dosimetry and tumor uptake of the GRPr antagonist ⁶⁴Cu-CB-TE2A-AR06 [(⁶⁴Cu-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo(6.6.2)hexadecane)-PEG₄-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-LeuNH₂] were studied by PET/CT in four patients with newly diagnosed prostate cancer (T1c-T2b, Gleason 6-7). "
06/01/1980 - "The influence of mineral ol, squalane, squalene, hexadecane, or peanut oil and of the concentration of Tween 80 on the immunotherapeutic capability of emulsified Mycobacterium bovis Bacillus Calmette-Guérin (BCG) cell walls was studied in guinea pigs, each with an established dermal transplant of a syngeneic hepatocarcinoma and tumor cells in the draining lymph node. "
|1.||Mineral Oil (Liquid Paraffin)
|4.||Phenol (Carbolic Acid)
|5.||Palmitic Acid (Hexadecanoic Acid)
|6.||Pyruvic Acid (Pyruvate)
|7.||Complementary DNA (cDNA)
|1.||Heterologous Transplantation (Xenotransplantation)